What service do you need? Contact Request

NCT07668518

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD

← Hub

Registry fields

Overall status: RECRUITING
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Study type: INTERVENTIONAL
Phase: PHASE1, PHASE2
Primary purpose: TREATMENT
Intervention type: DRUG
Interventions: KIT2014, Placebo
Lead sponsor: Kither Biotech Srl (INDUSTRY)

Cached at: 2026-09-10 09:07:52

View on ClinicalTrials.gov

Brief summary

Study investigating the safety, tolerability, pharmacokinetics and early efficacy with KIT2014 over 7 days of treatment in moderate to severe chronic obstructive pulmonary disease patients.

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report